UPDATE: JPMorgan Downgrades Teladoc (TDOC) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/16/2026
Teladoc (TDOC) PT Lowered to $30 at Craig-Hallum
April 28, 2022 8:56 AM EDTCraig-Hallum analyst Matthew G. Hewitt lowered the price target on Teladoc (NYSE: TDOC) to $30.00 (from $67.00) while maintaining a Hold rating.... More
Pre-Open Stock Movers 04/28: Facebook, ServiceNow, and Qualcomm Gain on Earnings; Teladoc Tumbles (more...)
April 28, 2022 8:53 AM EDTPre-Open Stock Movers:
Teladoc (NYSE: TDOC) 44% LOWER; reported Q1 EPS of ($41.58), which may not compare to the analyst estimate of ($0.56). Revenue for the quarter came in at $565.4 million versus the consensus estimate of $568.8 million. Net loss per share of $41.58, primarily driven by non-cash goodwill impairment charge of $6.6 billion or $41.11 per share. Teladoc sees FY2022 EPS of ($43.50)-($43.00), may not compare versus the consensus of ($1.53). Teladoc sees FY2022 revenue of $2.4-2.5 billion, versus the consensus of $2.58 billion.
Sio Gene Therapies Inc. (NASDAQ:... More
SVB Leerink Downgrades Teladoc (TDOC) to Market Perform
April 28, 2022 8:53 AM EDTSVB Leerink analyst Stephanie Davis downgraded Teladoc (NYSE: TDOC) from Outperform to Market Perform with a price target of $35.00.
For an analyst ratings summary and ratings history on Teladoc click here. For more ratings news on Teladoc click here.
Shares of Teladoc closed at $55.99 yesterday.
... MoreTeladoc (TDOC) PT Lowered to $44 at Deutsche Bank
April 28, 2022 7:58 AM EDTDeutsche Bank analyst George Hill lowered the price target on Teladoc (NYSE: TDOC) to $44.00 (from $78.00) while maintaining a Hold rating.... More
Teladoc (TDOC) Stock Crashes 40% on 'Alarming' Outlook, Several Analysts Downgrade to Neutral
April 28, 2022 7:43 AM EDTShares of Teladoc Health (NYSE: TDOC) are down as much as 41% in premarket trading Thursday after the company reported disappointing Q1 results.
Teladoc reported a Q1 loss per share of $41.58, including a goodwill impairment charge of $6.6 billion, which may not compare with an expected loss per share of 60c.
Adjusted EBITDA loss in the quarter totaled $54.5 million, compared to a $56.6 million profit in the same period last year and profit estimates of $53 million. Revenue came in at $565.4 million, up 25% YoY and missing the consensus estimates of $568.9 million.
For Q2, Teladoc... More
Guggenheim Downgrades Teladoc (TDOC) to Neutral
April 28, 2022 6:55 AM EDTGuggenheim analyst Sandy Draper downgraded Teladoc (NYSE: TDOC) from Buy to Neutral.
For an analyst ratings summary and ratings history on Teladoc click here. For more ratings news on Teladoc click here.
Shares of Teladoc closed at $55.99 yesterday.
... MoreTeladoc (TDOC) PT Lowered to $58 at Cowen
April 28, 2022 6:39 AM EDTCowen analyst Charles Rhyee lowered the price target on Teladoc (NYSE: TDOC) to $58.00 (from $94.00) while maintaining a Outperform rating.
The analyst commented, "1Q22 was mixed w/ rev of $565.4M vs. cons. $568.7M. Adj. EBITDA of $54.5M was above cons. $52.9M. 2022... More
UPDATE: Wells Fargo Downgrades Teladoc (TDOC) to Equal-weight (correction)
April 28, 2022 6:35 AM EDT(Updated - April 28, 2022 7:58 AM EDT)
Wells Fargo analyst Stephen Baxter downgrades Teladoc (NYSE: TDOC) from Overweight to Equal-weight with a price target of $40.00 (from $104.00).
For an analyst ratings summary and ratings history on Teladoc click here. For more ratings news on Teladoc click here.
Shares of Teladoc closed at $55.99 yesterday.
... MoreTeladoc (TDOC) Faces Market Saturation and Increasing Competition, PT Lowered to $45 at Stifel
April 28, 2022 6:34 AM EDTStifel analyst David Grossman lowered the price target on Teladoc (NYSE: TDOC) to $45.00 (from $74.00) after the company missed 1Q revenue/EBITDA and lowered annual guidance citing higher ad costs/lower yields in D2C markets for behavioral and longer chronic care (CCM) sales... More
Teladoc (TDOC) PT Lowered to $65 at RBC Capital
April 28, 2022 6:26 AM EDTRBC Capital analyst Sean Dodge lowered the price target on Teladoc (NYSE: TDOC) to $65.00 (from $120.00) while maintaining a Outperform rating.... More
Citi Downgrades Teladoc (TDOC) to Neutral
April 28, 2022 5:38 AM EDTCiti analyst Daniel GrosslightN downgraded Teladoc (NYSE: TDOC) from Buy to Neutral with a price target of $43.00.
For an analyst ratings summary and ratings history on Teladoc click here. For more ratings news on Teladoc click here.
Shares of Teladoc closed at $55.99 yesterday.
... MoreWilliam Blair Downgrades Teladoc (TDOC) to Market Perform
April 28, 2022 5:37 AM EDTWilliam Blair analyst Ryan Daniels downgraded Teladoc (NYSE: TDOC) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Teladoc click here. For more ratings news on Teladoc click here.
Shares of Teladoc closed at $55.99 yesterday.
... MoreCredit Suisse Downgrades Teladoc (TDOC) to Neutral
April 28, 2022 5:33 AM EDTCredit Suisse analyst A.J. Rice downgraded Teladoc (NYSE: TDOC) from Outperform to Neutral with a price target of $35.00.
For an analyst ratings summary and ratings history on Teladoc click here. For more ratings news on Teladoc click here.
Shares of Teladoc closed at $55.99 yesterday.
... MoreAfter-Hours Stock Movers 04/27: Facebook Surges on Earnings; Teladoc, Align Fall After Results (more...)
April 27, 2022 5:57 PM EDTAfter-Hours Stock Movers:
Teladoc (NYSE: TDOC) 38% LOWER; reported Q1 EPS of ($41.58), which may not compare to the analyst estimate of ($0.56). Revenue for the quarter came in at $565.4 million versus the consensus estimate of $568.8 million. Net loss per share of $41.58, primarily driven by non-cash goodwill impairment charge of $6.6 billion or $41.11 per share. Teladoc sees FY2022 EPS of ($43.50)-($43.00), may not compare versus the consensus of ($1.53). Teladoc sees FY2022 revenue of $2.4-2.5 billion, versus the consensus of $2.58 billion.
Meta Platforms (NASDAQ:... More
Teladoc (TDOC) Q1 Revenue Misses Consensus, Offers Guidance
April 27, 2022 4:10 PM EDTTeladoc (NYSE: TDOC) reported Q1 EPS of ($41.58), may not compare to the analyst estimate of ($0.56). Revenue for the quarter came in at $565.4 million versus the consensus estimate of $568.8 million.
Net loss per share of $41.58, primarily driven by non-cash goodwill impairment charge of $6.6... MoreTeladoc (TDOC) call put ratio 1 call to 1.3 puts into quarter results and outlook
April 27, 2022 10:37 AM EDTTeladoc (NYSE: TDOC) April weekly call option implied volatility is at 220, May is at 105; compared to its 52-week range of 39 to 107 into the expected release of quarter results today after the bell. Call put ratio 1 call to 1.3 puts.
... MoreTeladoc (TDOC) April weekly 58 straddle into quarter results
April 27, 2022 4:02 AM EDTTeladoc (NYSE: TDOC) April weekly 58 straddle priced for a move of 13% into the expected release of quarter results today after the bell.
... MoreTeladoc (TDOC) option implied volatility into quarter results
April 27, 2022 3:48 AM EDTTeladoc (NYSE: TDOC) 30-day option implied volatility is at 93; compared to its 52-week range of 38 to 107 into the expected release of quarter results today after the bell.
... MoreTeladoc (TDOC) call put ratio 1 call to 1 put as shares sell off 2.7% into quarter results and outlook
April 26, 2022 3:07 PM EDTTeladoc (NYSE: TDOC) 30-day option implied volatility is at 93; compared to its 52-week range of 38 to 107 into the expected release of quarter results after the bell on April 27.
... MoreTeladoc's mental health unit in focus as cost concerns mount
April 26, 2022 1:11 PM EDTBy Amruta Khandekar
(Reuters) - Teladoc Health's mental health services unit will grab focus when the largest U.S. telehealth company reports first-quarter earnings on Wednesday, with investors worried that growth will be eclipsed by rising costs in a competitive market.
The mental healthcare sector has grown in prominence over the past two years as the COVID-19 crisis boosted demand for such services and prompted more firms to offer virtual therapy.
"TDOC is having to spend more in advertising and marketing to achieve user growth, and we see profitability metrics becoming increasingly... More
